BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease...

* Reuters is not responsible for the content in this press release.

Mon Jun 1, 2009 8:41am EDT

BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments
in Disease and Drug Development Research

Special Order BD LSRFortessa(TM) Benchtop Flow Cytometry System Supports up to
Five Lasers and 18 Colors Simultaneously 

SAN JOSE, Calif., June 1 /PRNewswire/ -- BD Biosciences, a segment of BD
(Becton, Dickinson and Company), announced today the launch of the new special
order BD LSRFortessa(TM) cell analyzer, a powerful compact system that
provides life science researchers with the ability to conduct complex
multicolor flow cytometry experiments.  

"Our special order research products program combines the knowledge gained
from decades of working closely with leading researchers and excelling in
manufacturing," said Jay Glasscock, President, Cell Analysis, BD Biosciences. 
"It allows us to work closely with customers to configure a BD LSRFortessa
system that meets their exact specifications."

The BD LSRFortessa system offers power and flexibility in a benchtop footprint
that is significantly smaller than the industry leading BD(TM) LSR II cell
analyzer.  It is the only compact cell analyzer that supports up to five
lasers.  Researchers can choose from 30 positions for detectors and 11 laser
wavelengths and multiple power options to detect up to 18 colors
simultaneously.  Working with BD Biosciences' flow cytometry experts,
laboratories can configure a system that meets their precise assay
requirements.  

"Space is at a premium in most research settings, leading many labs to
compromise system power and performance because of space limitations," said
Glasscock.  "The new BD LSRFortessa system eliminates the need for that
sacrifice by addressing researchers' growing analytical needs and helping to
maximize lab space utilization at the same time."

The BD LSRFortessa system is the newest addition to the proven line of BD(TM)
LSR cell analyzers.  The original BD LSR II system supports up to seven lasers
and has been the preferred tool of life science researchers worldwide working
in core, academic, pharmaceutical and biotechnology laboratories.  

For more information about the BD LSRFortessa cell analyzer, as well as the
complete BD LSR product line, please visit: http://www.bdbiosciences.com/lsr.

About BD
BD is a leading global medical technology company that develops, manufactures
and sells medical devices, instrument systems and reagents.  The Company is
dedicated to improving people's health throughout the world.  BD is focused on
improving drug delivery, enhancing the quality and speed of diagnosing
infectious diseases and cancers, and advancing research, discovery and
production of new drugs and vaccines.  BD's capabilities are instrumental in
combating many of the world's most pressing diseases.  Founded in 1897 and
headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000
people in approximately 50 countries throughout the world.  The Company serves
healthcare institutions, life science researchers, clinical laboratories, the
pharmaceutical industry and the general public.  For more information, please
visit http://www.bd.com.








SOURCE  BD-Becton Dickinson

Jeff Ezell, Public Relations, +1-201-847-5533, jeff_ezell@bd.com, for
BD-Becton Dickinson
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.